AGP Executive Report
Last update: 12 hours agoMedical Device & Regulatory Watch: Implantica’s Interim Report (Jan–Jun 2026) highlights ongoing progress, while RefluxStop®: FDA PMA approval is secured and U.S. launch prep begins, with Q2 sales up 66% to TEUR 717 and a large multi-center safety study in Nature’s Scientific Reports (602 patients). Transplant News: Australia’s first commercial living-donor kidney transplant using Hansa Biopharma’s Idefirix (imlifidase) marks a step forward for highly sensitised patients. Public Health & Safety: Norway’s King Harald (89) was rushed to hospital for fluid accumulation after cortisone treatment for hemolytic anaemia, with the Crown Prince acting as regent. Digital Health & Privacy: France’s DGFiP breach exposed detailed tax and withholding data for ~678,000 people, raising the risk of highly convincing impersonation scams. AI & Health Tech Context: ChatGPT Ads roll out across 31 European markets including Liechtenstein, but personalized ads aren’t available in the EEA/Switzerland yet.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.